Amy leads Novo Nordisk US in identifying transformational digital opportunities and breakthrough innovations that enhance patient healthcare experiences, outcomes. Amy oversees opportunity exploration, testing and market validation through Novo Nordisk’s internal incubator as well as with partnerships including start-ups, entrepreneurs and third-party accelerator/incubators to test pilots and scale viable solutions. Amy has over 25 years of strategic marketing and business development experience, including work in both the client and agency environments, across a broad range of disciplines including digital and commercial innovation, DTC, HCP/Professional and B2B omni-channel marketing, CRM and database management. She is a 2018 MM&M top 40 Healthcare Transformer. In 2013 she was awarded the PM 360 Trailblazer award winner in the Diabetes/Metabolic Disease category